Hans Severens is a seasoned expert in Health Technology Assessment (HTA) and Market Access (MA) with a proven track record of success in academia and decision making bodies such as ZIN, NICE and the Dutch Health Council. As the founder of Severens HTA Consultancy, he brings a wealth of knowledge and experience to help organizations navigate the complex landscape of pricing, access, and evidence generation. With a deep understanding of the European healthcare system, Hans is dedicated to indepently provide scientific and strategic advice in the field of HTA/MA to his clients to ensure patients have timely access to innovative therapies. His expertise lies in conducting rigorous evaluations of healthcare interventions, providing evidence-based recommendations to support decision-making processes. He participated in numerous international advisory boards for pharma industry eversince he started as an independent consultant over five years ago. Hans is a sought-after speaker and thought leader in the field, known for his insightful perspectives on the evolving trends and challenges in healthcare pricing and access. With a commitment to driving positive change in the industry, Hans is passionate about advancing the conversation on healthcare affordability and sustainability. Attendees at the World EPA Congress 2027 can expect to gain valuable insights and practical strategies from Hans Severens to enhance their pricing and access initiatives in an ever-changing healthcare landscape.